STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
153
13F, latest reported quarter
What the filings say about ADNT
Insiders, 180 days
-$666.4K net sold
3 sellers · 0% of sales under a 10b5-1 plan
Adient insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Adient plc insiders sold a net $666.4K of stock across 28 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Feb 14, 2024.
The trade is 19.8% of the 110,886 shares held after it.
1 other insider sold within 30 days.
153 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, CLO, CHRO & Secretary Tiltmann Heather M sold about $499.6K of ADNT on Jun 4, 2026, the largest insider sale at the company since 2023; 1 other insider sold within 30 days and 153 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 1.7% of the 40,122 shares held after it.
1 other insider sold within 30 days.
153 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, EMEA Herberg David sold about $15.8K of ADNT on Jun 4, 2026; 1 other insider sold within 30 days and 153 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Dec 15, 2023.
The trade is 2.7% of the 441,025 shares held after it.
No other insider sold within 30 days.
153 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Dorlack Jerome J. sold about $273.2K of ADNT on Aug 7, 2025, the largest insider sale at the company since 2024; 153 funds added in the latest 13F quarter.
28 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
ADNT planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
ADNT mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Invesco S&P SmallCap Value with Momentum ETF
$9.4M position · as of 2026-07-31
1.4%
Invesco S&P SmallCap 600 Revenue ETF
$17.6M position · as of 2026-05-31
0.9%
Invesco S&P Smallcap 600 Pure Value ETF
$2.5M position · as of 2026-07-31
0.8%
Invesco S&P SmallCap Consumer Discretionary ETF
$173.4K position · as of 2026-05-31
0.8%
iShares Self-Driving EV and Tech ETF
$818.6K position · as of 2026-07-31
0.6%
NAA SMID-CAP VALUE SERIES
$420.1K position · as of 2026-06-30
0.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr Del Grosso
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$14.7M
$27.7M
$3.0M
+112%
+18%
2022
$15.4M
$4.6M
$3.4M
+60%
-2%
2021
$14.2M
$35.0M
$3.1M
+139%
+38%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $666.4K sold by insiders over 180 days, 153 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$15.1B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM ADNT
FY Sep 2025
$14.5B
FY Sep 2024
$14.7B
FY Sep 2023
$15.4B
FY Sep 2022
$14.1B
FY Sep 2021
$13.7B
Jun 2026
$3.9B
Mar 2026
$3.9B
Dec 2025
$3.6B
Sep 2025
$3.7B
Jun 2025
$3.7B
Mar 2025
$3.6B
Dec 2024
$3.5B
Sep 2024
$3.6B
At each fiscal year end
Single quarter
Net margin, TTM
+0.3%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM ADNT
FY Sep 2025
-1.9%
FY Sep 2024
+0.1%
FY Sep 2023
+1.3%
FY Sep 2022
-0.8%
FY Sep 2021
+8.1%
Jun 2026
+0.6%
Mar 2026
+0.7%
Dec 2025
-0.6%
Sep 2025
+0.5%
Jun 2025
+1.0%
Mar 2025
-9.3%
Dec 2024
+0.0%
Sep 2024
+2.2%
At each fiscal year end
Single quarter
Free cash flow, TTM
$295.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM ADNT
FY Sep 2025
$204.0M
FY Sep 2024
$277.0M
FY Sep 2023
$415.0M
FY Sep 2022
$47.0M
FY Sep 2021
$0
Jun 2026
$138.0M
Mar 2026
$8.0M
Dec 2025
$15.0M
Sep 2025
$134.0M
Jun 2025
$115.0M
Mar 2025
-$90.0M
Dec 2024
$45.0M
Sep 2024
$191.0M
At each fiscal year end
Single quarter
Debt to equity
1.38x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity ADNT
FY Sep 2025
1.35x
FY Sep 2024
1.12x
FY Sep 2023
1.08x
FY Sep 2022
1.24x
FY Sep 2021
1.49x
Jun 2026
1.38x
Mar 2026
1.39x
Dec 2025
1.37x
Sep 2025
1.35x
Jun 2025
1.34x
Mar 2025
1.45x
Dec 2024
1.28x
Sep 2024
1.12x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.24x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt ADNT
FY Sep 2025
0.19x
FY Sep 2024
0.23x
FY Sep 2023
0.28x
FY Sep 2022
0.11x
FY Sep 2021
0.07x
Jun 2026
0.24x
Mar 2026
0.23x
Dec 2025
0.18x
Sep 2025
0.19x
Jun 2025
0.21x
Mar 2025
0.20x
Dec 2024
0.26x
Sep 2024
0.23x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+2.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity ADNT
FY Sep 2025
-14.4%
FY Sep 2024
+0.8%
FY Sep 2023
+9.5%
FY Sep 2022
-5.4%
FY Sep 2021
+61.7%
Jun 2026
+2.7%
Mar 2026
+3.5%
Dec 2025
-16.8%
Sep 2025
-14.4%
Jun 2025
-11.9%
Mar 2025
-14.3%
Dec 2024
-0.1%
Sep 2024
+0.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ADNT
FY Sep 2025
-3.1%
FY Sep 2024
+0.2%
FY Sep 2023
+2.2%
FY Sep 2022
-1.2%
FY Sep 2021
+10.5%
Jun 2026
+0.5%
Mar 2026
+0.7%
Dec 2025
-3.5%
Sep 2025
-3.1%
Jun 2025
-2.5%
Mar 2025
-3.0%
Dec 2024
-0.0%
Sep 2024
+0.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital ADNT
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed ADNT
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
30.65x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing ADNT
FY Sep 2025
n/a
FY Sep 2024
118.79x
FY Sep 2023
16.99x
FY Sep 2022
n/a
FY Sep 2021
3.58x
Jun 2026
33.42x
Mar 2026
30.62x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
118.79x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.8B
market value at close 2026-10-27 on 2026-06-30 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2019-09-30
Enterprise value ADNT
FY Sep 2025
$3.4B
FY Sep 2024
$3.4B
FY Sep 2023
$4.9B
FY Sep 2022
$4.3B
FY Sep 2021
$6.5B
Jun 2026
$2.9B
Mar 2026
$3.0B
Dec 2025
$3.0B
Sep 2025
$3.4B
Jun 2025
$3.0B
Mar 2025
$2.5B
Dec 2024
$2.9B
Sep 2024
$3.4B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+22.7%
TTM free cash flow over market value at close 2026-10-27
FCF yield ADNT
FY Sep 2025
+10.7%
FY Sep 2024
+14.5%
FY Sep 2023
+12.1%
FY Sep 2022
+1.8%
FY Sep 2021
+0.0%
Jun 2026
+20.8%
Mar 2026
+17.2%
Dec 2025
+11.6%
Sep 2025
+10.7%
Jun 2025
+16.5%
Mar 2025
+21.7%
Dec 2024
+23.2%
Sep 2024
+14.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing ADNT
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
ADNT ranks highest on risk and compliance (63rd percentile) and institutional and government (56th), and lowest on insider conviction (19th), among Autos peers.
Profitability
46
Inputs
Return on equity+2.7% · 48 pct, sector of 51
Return on assets+0.5% · 43 pct, sector of 61
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
36
Inputs
Debt to equity1.38x · 16 pct, sector of 63
Cash flow to debt0.24x · 55 pct, sector of 52
Growth
34
Inputs
Revenue growth, YoY-1.0% · 34 pct, sector of 78
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
19
Inputs
Net Form 4 buying (codes P and S), 180d-$666K · 38 pct, sector of 46
Insider buyers, 180d0 · 0 pct, sector of 47
Institutional and government
56
Inputs
Funds adding, latest quarter153 · 56 pct, sector of 60
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
63
Inputs
Short interest, % of float+8.8% · 25 pct, sector of 92
Recalls per $1B revenue, 3y0.00 per $1B · 100 pct, sector of 54
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+10.8% · 65 pct, sector of 58
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ADNT filings, in plain words
Are Adient insiders buying or selling ADNT?
In the 180 days to 2026-10-27, Adient insiders were net sellers, a net $666.4K across purchases and sales reported on Form 4, by 3 sellers.
Read the full summary
In the 180 days to 2026-10-27, Adient insiders were net sellers of ADNT, a net $666.4K across purchases and sales reported on Form 4 by 3 sellers. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.